The anticancer efficacy of sorafenib was related to the inhibition of CRC cell growth through the inhibition of MAPK signal transduction via RAF downregulation, and enhanced antitumor effect of sorafenib was possible following the inhibition of sub-signals from FAK downregulation mediated by calcium influx (Figure 5). The gene discussed is PTK2; the disease is colorectal carcinoma.